149 related articles for article (PubMed ID: 30320362)
1. Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation.
Jin J; Jin J; Woodfield SE; Patel RH; Jin NG; Shi Y; Liu B; Sun W; Chen X; Yu Y; Vasudevan SA
Oncol Rep; 2019 Jan; 41(1):143-153. PubMed ID: 30320362
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells.
Hsiao CC; Chen PH; Cheng CI; Tsai MS; Chang CY; Lu SC; Hsieh MC; Lin YC; Lee PH; Kao YH
Cancer Lett; 2015 Nov; 368(1):144-152. PubMed ID: 26276725
[TBL] [Abstract][Full Text] [Related]
3. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
4. GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3.
Pei Y; Yao Q; Yuan S; Xie B; Liu Y; Ye C; Zhuo H
Oncotarget; 2016 Nov; 7(47):77890-77901. PubMed ID: 27788486
[TBL] [Abstract][Full Text] [Related]
5. Nuclear receptor mRNA expression by HBV in human hepatoblastoma cell lines.
Wu S; Kanda T; Imazeki F; Nakamoto S; Shirasawa H; Yokosuka O
Cancer Lett; 2011 Dec; 312(1):33-42. PubMed ID: 21903321
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
Martínez-Fernández P; Hierro L; Jara P; Alvarez L
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of hepatic lipase is associated with decreased CD133 expression and clone formation in HepG2 cells.
Liu X; Zuo J; Fang Y; Wen J; Deng F; Zhong H; Jiang B; Wang J; Nie B
Int J Mol Med; 2018 Oct; 42(4):2137-2144. PubMed ID: 30015857
[TBL] [Abstract][Full Text] [Related]
9. Enhancer of zeste homolog 2 depletion arrests the proliferation of hepatoblastoma cells.
Wang Y; Xiao Y; Chen K; Chen S; Zhang M; Wu Z; Wu Y
Mol Med Rep; 2016 Mar; 13(3):2724-8. PubMed ID: 26848027
[TBL] [Abstract][Full Text] [Related]
10. Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells.
Eberherr C; Beck A; Vokuhl C; Becker K; Häberle B; Von Schweinitz D; Kappler R
Int J Oncol; 2019 May; 54(5):1853-1863. PubMed ID: 30864675
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
Lieber J; Kirchner B; Eicher C; Warmann SW; Seitz G; Fuchs J; Armeanu-Ebinger S
Pediatr Blood Cancer; 2010 Dec; 55(6):1089-95. PubMed ID: 20680965
[TBL] [Abstract][Full Text] [Related]
12. LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.
Wang S; Zou Z; Luo X; Mi Y; Chang H; Xing D
Oncogene; 2018 Jun; 37(24):3243-3259. PubMed ID: 29545602
[TBL] [Abstract][Full Text] [Related]
13. Lycorine inhibits cell proliferation and migration by inhibiting ROCK1/cofilin‑induced actin dynamics in HepG2 hepatoblastoma cells.
Liu W; Zhang Q; Tang Q; Hu C; Huang J; Liu Y; Lu Y; Wang Q; Li G; Zhang R
Oncol Rep; 2018 Oct; 40(4):2298-2306. PubMed ID: 30066939
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
15. Development of a drug resistance model for hepatoblastoma.
Eicher C; Dewerth A; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
Int J Oncol; 2011 Feb; 38(2):447-54. PubMed ID: 21132272
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.
Ilmer M; Garnier A; Vykoukal J; Alt E; von Schweinitz D; Kappler R; Berger M
Mol Cancer Ther; 2015 Dec; 14(12):2712-21. PubMed ID: 26516161
[TBL] [Abstract][Full Text] [Related]
17. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.
Martinez-Becerra P; Vaquero J; Romero MR; Lozano E; Anadon C; Macias RI; Serrano MA; Grañé-Boladeras N; Muñoz-Bellvis L; Alvarez L; Sangro B; Pastor-Anglada M; Marin JJ
Mol Pharm; 2012 Jun; 9(6):1693-704. PubMed ID: 22524153
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of
Liu L; Cui Z; Zhang J; Wang J; Gu S; Ma J; Chen H; Hang L; Yang J; Shi Y
Cancer Biother Radiopharm; 2020 Feb; 35(1):41-49. PubMed ID: 31916845
[No Abstract] [Full Text] [Related]
19. Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival.
Hartmann W; Küchler J; Koch A; Friedrichs N; Waha A; Endl E; Czerwitzki J; Metzger D; Steiner S; Wurst P; Leuschner I; von Schweinitz D; Buettner R; Pietsch T
Clin Cancer Res; 2009 Jul; 15(14):4538-45. PubMed ID: 19584164
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.
Jiang MC; Yang-Yen HF; Lin JK; Yen JJ
Oncogene; 1996 Aug; 13(3):609-16. PubMed ID: 8760302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
